Research, development, and manufacturing of innovative therapies for serious diseases using biotechnology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
AstraZeneca
B
Research and development of pharmaceuticals and biotechnologies for various diseases, including cardiovascular, renal, and metabolic diseases.
Genethon
B
Research and development of gene therapy medicines for the treatment of rare diseases.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Initiatives identified among leaders
Mesure et publication annuelle des émissions GES Scope 3
“AstraZeneca publie des données détaillées sur ses ...” - AstraZenecaSuivi des émissions et consommation énergétique des sites
“AstraZeneca mesure et publie des indicateurs envir...” - AstraZenecaPlantation de 200 millions d'arbres pour restaurer les écosystèmes et communautés.
“AZ Forest est une initiative mondiale visant à pla...” - AstraZeneca64% of similar organizations communicate on CSR issues
+1415 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports